Ravi Singisetti; Chief Executive Officer, Director; Cognizant Technology Solutions Corp Jatin Dalal; Chief Financial Officer; Cognizant Technology Solutions Corp Thank you, operator, and good ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines ...

Cognizant has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences that aims to unlock even greater value for Gilead as it advances innovations to ...

TEANECK, N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD ...

A combination of homegrown capabilities and significant acquisitions has made Cognizant a key player in bringing AI to ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions' Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...

Cognizant Technology Solutions CTSH is scheduled to report its fourth-quarter 2024 results on Feb. 05. The Zacks Consensus ...

and user acceptanc Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even ...

Pre-earnings options volume in Cognizant (CTSH) is 2.8x normal with puts leading calls 9:8. Implied volatility suggests the market is ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Gilead Sciences (GILD – Research Report), with a price ...